IL67040A - N-nitroso-n-(beta-chloro ethyl)-carbamoyl peptides,their preparation and pharmaceutical compositions comprising them - Google Patents

N-nitroso-n-(beta-chloro ethyl)-carbamoyl peptides,their preparation and pharmaceutical compositions comprising them

Info

Publication number
IL67040A
IL67040A IL67040A IL6704082A IL67040A IL 67040 A IL67040 A IL 67040A IL 67040 A IL67040 A IL 67040A IL 6704082 A IL6704082 A IL 6704082A IL 67040 A IL67040 A IL 67040A
Authority
IL
Israel
Prior art keywords
preparation
nitroso
carbamoyl
peptides
beta
Prior art date
Application number
IL67040A
Other languages
English (en)
Other versions
IL67040A0 (en
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of IL67040A0 publication Critical patent/IL67040A0/xx
Publication of IL67040A publication Critical patent/IL67040A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL67040A 1981-10-22 1982-10-21 N-nitroso-n-(beta-chloro ethyl)-carbamoyl peptides,their preparation and pharmaceutical compositions comprising them IL67040A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU813073A HU187461B (en) 1981-10-22 1981-10-22 Process for producing n-nitrozo-n-bracket-beta-chloroethyl-bracket closed-carbamoyl-peptides of citostatic activity

Publications (2)

Publication Number Publication Date
IL67040A0 IL67040A0 (en) 1983-02-23
IL67040A true IL67040A (en) 1985-11-29

Family

ID=10962415

Family Applications (1)

Application Number Title Priority Date Filing Date
IL67040A IL67040A (en) 1981-10-22 1982-10-21 N-nitroso-n-(beta-chloro ethyl)-carbamoyl peptides,their preparation and pharmaceutical compositions comprising them

Country Status (11)

Country Link
US (1) US4950651A (fi)
EP (1) EP0078167B1 (fi)
JP (1) JPS5888349A (fi)
AT (1) ATE32342T1 (fi)
DE (1) DE3278075D1 (fi)
DK (1) DK468482A (fi)
FI (1) FI77672C (fi)
GR (1) GR76768B (fi)
HU (1) HU187461B (fi)
IL (1) IL67040A (fi)
SU (3) SU1424739A3 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057367A (en) 1996-08-30 2000-05-02 Duke University Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
GB0918579D0 (en) * 2009-10-22 2009-12-09 Imp Innovations Ltd Gadd45beta targeting agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3814746A (en) * 1970-08-05 1974-06-04 Inst Sieroterapico Milanese Se Mannich base of tetracycline and polypeptides

Also Published As

Publication number Publication date
DE3278075D1 (de) 1988-03-10
JPS5888349A (ja) 1983-05-26
FI823591A0 (fi) 1982-10-20
SU1414851A1 (ru) 1988-08-07
FI77672B (fi) 1988-12-30
IL67040A0 (en) 1983-02-23
HU187461B (en) 1986-01-28
GR76768B (fi) 1984-09-03
ATE32342T1 (de) 1988-02-15
SU1424739A3 (ru) 1988-09-15
EP0078167A1 (en) 1983-05-04
FI823591L (fi) 1983-04-23
FI77672C (fi) 1989-04-10
SU1586520A3 (ru) 1990-08-15
DK468482A (da) 1983-04-23
US4950651A (en) 1990-08-21
EP0078167B1 (en) 1988-02-03

Similar Documents

Publication Publication Date Title
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
MD1233B1 (en) Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
MY130125A (en) Ureido derivatives of naphthalenephosphonic acids and process for their preparation
CA2120942A1 (en) Nitric esters of derivatives of the 2-(2,6-di-halo-phenylamino)phenyl-acetic acid and process for their preparation
HU913331D0 (en) Peptides and process for their production
IE792027L (en) Pyrroloazetidinones
CA2238859A1 (en) Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
HUT61780A (en) Process for producing new peptides and pharmaceutical compositions comprising same as active ingredient
ES8502417A1 (es) "un procedimiento para obtener de orina una fraccion que contiene un ingrediente antineoplastico de naturaleza peptidica".
BG103197A (en) Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptiees
ES8703464A1 (es) Procedimiento para preparar pirazol (3,4-b) piridinamidas.
ES8800235A1 (es) Un procedimiento para preparar un isomero sin de un compues-to de cefem
HUT50789A (en) Process for producing renin inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
IL67040A (en) N-nitroso-n-(beta-chloro ethyl)-carbamoyl peptides,their preparation and pharmaceutical compositions comprising them
ES8205224A1 (es) Un procedimiento para la preparacion de acidos 1-carbadetiapen-2-em-3-carboxilios 6-1-y 2-sustituidos.
EP0333000A3 (en) Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them
IE790619L (en) Psychopharmacological peptides
ES473090A1 (es) Un procedimiento para la preparacion de l-(piro)glutamil-l- histidil-glicina
ZA888335B (en) Vincristine-containing product
WO1987004435A3 (en) Xanthine compounds
HUT53121A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DE68909451D1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ZA934708B (en) Peptide compounds active in cell adhesion processes, a process for the preparation thereof, and pharmaceutical compositions containing them
HU208308B (en) Process for producing acylated amino acid derivatives and pharmaceutical compositions comprising same as active ingredient